ReleaseWire Connect

The Global and Chinese Double Roller Crusher Industry, 2010-2020 Market Research Report is a professional and in-depth study on the current state of the global Double Roller Crusher industry with a focus on the Chinese market. The report provides key statistics on the market status of the Double Roller Crusher manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

DelveInsight's, 5-HT3 Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the 5-HT3 Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT3 Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

In recent years, the global industrial enzyme preparation market size increased year by year, registering a CAGR of 5%, approximating USD4.2178 billion in 2014. At present, the global industrial enzyme market is basically an oligopoly. In 2014, Novozymes, an industrial enzyme giant, accounted for a 44% market share while that for Dupont and DSM was 20% and 6%, respectively.

China's animation industry output value continued to grow and exceeded RMB90 billion in 2013, showing a year-on-year increase of around 21.0%. Despite the overall sustained growth, each link of the industrial chain is developing to varying degrees.

DelveInsight's, Opioid Receptor Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Opioid Receptor Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Opioid Receptor Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, Selective COX-2 Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Selective COX-2 Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Selective COX-2 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, Anti-CD25 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD25 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD25 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Calcium stearate, one of the most commonly used metallic stearate for industrial and commercial applications, is a nontoxic and non-irritating carboxylate of calcium. It is commercially produced by the reaction of stearic acid with calcium oxide. It is sold in the form of a white waxy powder.

Smart grid is the integration and implementation of communication, automation and IT systems with the traditional electrical grid with the ability to monitor and control power flows from points of generation to consumption and manage the load to match generation in real-time or near real-time. Smart grid increases the predictability, visibility and control of generation and demand, bringing flexibility to the whole system. This facilitates the integration of intermittent energy from renewable generation and peak load management, which helps reduce the costs of peak power. The transformation of electrical grids to smarter grids depends on various smart grid equipment.

DelveInsight's, Mitogen-Activated Protein (MAP) Kinase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Mitogen-Activated Protein (MAP) Kinase Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Mitogen-Activated Protein (MAP) Kinase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.